Cellular senescence: a reflection of normal growth control, differentiation, or aging?
Normal cells, with few exceptions, cannot proliferate indefinitely. Cell populations--in vivo and in culture--generally undergo only a limited number of doublings before proliferation invariably and irreversibly ceases. This process has been termed the finite lifespan phenotype or cellular senescence. There is long-standing, albeit indirect, evidence that cellular senescence plays an important role in complex biological processes as diverse as normal growth control, differentiation, development, aging, and tumorigenesis. In recent years, it has been possible to develop a molecular framework for understanding some of the fundamental features of cellular senescence. This framework derives primarily from the physiology, genetics, and molecular biology of cells undergoing senescence in culture. Our understanding of senescence, and the mechanisms that control it, is still in its infancy. Nonetheless, recent data raise some intriguing possibilities regarding potential molecular bases for the links between senescence in culture and normal and abnormal growth control, differentiation, and aging.
Peacocke
M
M
Department of Dermatology, Boston University School of Medicine, Massachusetts 02118.
Campisi
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000473:pathology; D000818:Animals; D002454:Cell Differentiation; D002455:Cell Division; D002459:Cell Fusion; D002470:Cell Survival / Q000235:genetics; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D002478:Cells, Cultured; D005057:Eukaryotic Cells / Q000166:cytology; D005347:Fibroblasts / Q000166:cytology; D005786:Gene Expression Regulation; D006801:Humans; D008875:Middle Aged; D008954:Models, Biological; D010641:Phenotype; D011371:Progeria / Q000473:pathology; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis; D012377:Rodentia; D013045:Species Specificity
D011518:Proto-Oncogene Proteins